A CONTROLLED CLINICAL TRIAL OF ISONIAZID AND HETEROCYCLIC THIOSEMICARBAZONE COMPARED WITH ISONIAZID AND PAS IN PULMONARY TUBERCULOSIS.
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D001431:Bacteriological Techniques; D003919:Diabetes Insipidus; D004342:Drug Hypersensitivity; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004415:Dyspepsia; D007538:Isoniazid; D007565:Jaundice; D008111:Liver Function Tests; D011605:Psychoses, Substance-Induced; D011618:Psychotic Disorders; D013882:Thiosemicarbazones; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000636:Aminosalicylic Acids; D013882:Thiosemicarbazones; D010131:Aminosalicylic Acid; D007538:Isoniazid
AMINOSALICYLIC ACID; BACTERIOLOGICAL TECHNICS; DIABETES INSIPIDUS; DRUG HYPERSENSITIVITY; DRUG RESISTANCE, MICROBIAL; DYSPEPSIA; ISONIAZID; JAUNDICE; LIVER FUNCTION TESTS; PSYCHOSES, TOXIC; THIOSEMICARBAZONES; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY